{
 "companyname": "IBIO, INC.",
 "symbol": "IBIO",
 "description": "Pharmaceutical Preparations",
 "quarters": [
  {
   "cik": "0001420720",
   "companyname": "IBIO, INC.",
   "entityid": 772654,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IBIO",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/13/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2016,
   "fiscalquarter": 1,
   "dcn": "0001144204-15-065421",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -70000,
   "changeincurrentliabilities": 307000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": -8000,
   "capitalexpenditures": 0,
   "cashfromfinancingactivities": 63000,
   "cashfrominvestingactivities": -18000,
   "cashfromoperatingactivities": -1147000,
   "cfdepreciationamortization": 92000,
   "changeinaccountsreceivable": -160000,
   "investmentchangesnet": null,
   "netchangeincash": -1110000,
   "totaladjustments": 658000,
   "ebit": -1813000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 160000,
   "incomebeforetaxes": -1805000,
   "interestexpense": null,
   "netincome": -1805000,
   "netincomeapplicabletocommon": -1805000,
   "researchdevelopmentexpense": 551000,
   "totalrevenue": 160000,
   "sellinggeneraladministrativeexpenses": 1422000,
   "commonstock": 77000,
   "deferredcharges": null,
   "cashandcashequivalents": 8384000,
   "cashcashequivalentsandshortterminvestments": 8384000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 10000,
   "retainedearnings": -49632000,
   "totalassets": 11374000,
   "totalcurrentassets": 9080000,
   "totalcurrentliabilities": 1565000,
   "totalliabilities": 1565000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 606000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 9809000,
   "treasurystock": null
  },
  {
   "cik": "0001420720",
   "companyname": "IBIO, INC.",
   "entityid": 772654,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IBIO",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "10/13/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-K",
   "fiscalyear": 2015,
   "fiscalquarter": 4,
   "dcn": "0001144204-15-059224",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "true",
   "amended": false,
   "changeincurrentassets": 337000,
   "changeincurrentliabilities": 22000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": -14000,
   "capitalexpenditures": 2000,
   "cashfromfinancingactivities": 2698000,
   "cashfrominvestingactivities": -63000,
   "cashfromoperatingactivities": -1207000,
   "cfdepreciationamortization": 94000,
   "changeinaccountsreceivable": 220000,
   "investmentchangesnet": null,
   "netchangeincash": 1414000,
   "totaladjustments": 678000,
   "ebit": -1896000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 316000,
   "incomebeforetaxes": -1885000,
   "interestexpense": 0,
   "netincome": -1885000,
   "netincomeapplicabletocommon": -1885000,
   "researchdevelopmentexpense": 764000,
   "totalrevenue": 316000,
   "sellinggeneraladministrativeexpenses": 1448000,
   "commonstock": 77000,
   "deferredcharges": null,
   "cashandcashequivalents": 9494000,
   "cashcashequivalentsandshortterminvestments": 9494000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 13000,
   "retainedearnings": -47827000,
   "totalassets": 12494000,
   "totalcurrentassets": 10121000,
   "totalcurrentliabilities": 1263000,
   "totalliabilities": 1263000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 445000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 11231000,
   "treasurystock": null
  },
  {
   "cik": "0001420720",
   "companyname": "IBIO, INC.",
   "entityid": 772654,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IBIO",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/15/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001144204-15-031588",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 236000,
   "changeincurrentliabilities": -214000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": 4000,
   "capitalexpenditures": 0,
   "cashfromfinancingactivities": 2090000,
   "cashfrominvestingactivities": -52000,
   "cashfromoperatingactivities": -1325000,
   "cfdepreciationamortization": 89000,
   "changeinaccountsreceivable": 257000,
   "investmentchangesnet": null,
   "netchangeincash": 717000,
   "totaladjustments": 352000,
   "ebit": -1688000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 349000,
   "incomebeforetaxes": -1677000,
   "interestexpense": 0,
   "netincome": -1677000,
   "netincomeapplicabletocommon": -1677000,
   "researchdevelopmentexpense": 815000,
   "totalrevenue": 349000,
   "sellinggeneraladministrativeexpenses": 1222000,
   "commonstock": 74000,
   "deferredcharges": null,
   "cashandcashequivalents": 8080000,
   "cashcashequivalentsandshortterminvestments": 8080000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 14000,
   "retainedearnings": -45942000,
   "totalassets": 11446000,
   "totalcurrentassets": 9044000,
   "totalcurrentliabilities": 1254000,
   "totalliabilities": 1254000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 666000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 10192000,
   "treasurystock": null
  }
 ]
}